Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Fixed Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Fixed Capital/Sales(x) 0.760.820.890.620.48

What is the latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.76 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.76
Mar20240.82
Mar20230.89
Mar20220.62
Mar20130.48

How is Fixed Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.76
-7.32
Mar2024 0.82
-7.87
Mar2023 0.89
43.55
Mar2022 0.62
29.17
Mar2013 0.48 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Fixed Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹338.2 Cr 2.4% -6.9% -23.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,729.9 Cr -1.4% -7.9% -26.7% Stock Analytics
KAVERI SEED COMPANY ₹5,989.1 Cr 8.2% 4.1% 2.2% Stock Analytics
VENKYS (INDIA) ₹2,118.5 Cr 7.1% -3.4% -36.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,455.8 Cr 5.9% 1.3% -30.4% Stock Analytics
INDO US BIOTECH ₹302.8 Cr -4.4% -15% -45.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

2.4%

-6.9%

-23.8%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses